Gynecologic Cancers: Case 2

Gynecologic Cancers

EP. 1: Bradley J. Monk, MD, FACOG, FACS: Key Parameters to Determine Therapy

June 17th 2015

EP. 2: Bradley J. Monk, MD, FACOG, FACS: Safety Concerns Regarding Treatment

June 17th 2015

EP. 3: Bradley J. Monk, MD, FACOG, FACS: Patient Characteristics to Consider

June 17th 2015

EP. 4: Bradley J. Monk, MD, FACOG, FACS: Adding Bevacizumab to Cisplatin/Paclitaxel in Patient

June 17th 2015

EP. 5: Bradley J. Monk, MD, FACOG, FACS: Data in Support of Adding Antiangiogenesis Therapy To Current Treatment

June 17th 2015

EP. 6: Krishnansu S. Tewari, MD, FACOG, FACS: Key Parameters to Determine Therapy

June 17th 2015

EP. 7: Krishnansu S Tewari, MD, FACOG, FACS: Safety Concerns Regarding Treatment

June 17th 2015

EP. 8: Krishnansu S Tewari, MD, FACOG, FACS: Patient Characteristics to Consider

June 17th 2015

EP. 9: Krishnansu S. Tewari, MD, FACOG, FACS: Adding Bevacizumab to Cisplatin/Paclitaxel in Patient

June 17th 2015

EP. 10: Krishnansu S. Tewari, MD, FACOG, FACS: Data in Support of Adding Antiangiogenesis Therapy To Current Treatment

June 17th 2015